Category: Blog
-
Nodify Lung Testing: Blood-Based Biomarker Test for Lung Cancer
If you have been diagnosed with a lung nodule, you might be wondering if it is cancerous, and what happens next. You are not alone. Almost 50% of those who receive chest X-rays or CT scans are told they have a nodule. The good news is that about 95% of nodules turn out to be…
-
Infographic: What is a Lung Nodule?
Lung nodules can be a source of anxiety for people who discover they have them. However, 95% of lung nodules are benign, meaning they aren’t cancerous. Here is some information for Lung Cancer Awareness Month to help explain lung nodules.
-
Pulmonologists Responding to the COVID-19 Pandemic
The Nodify Lung™ testing service used for assessing the risk of malignancy of pulmonary nodules remains available. We understand that the coming weeks are going to be challenging as many of you will be required to suspend or reduce your clinics in order to respond to community needs in critical care facilities and prevent further…
-
CASE STUDY: Longitudinal Monitoring for the Emergence of EGFR C797S resistance mutations in NSCLC using blood-based Droplet Digital PCR
Bowling et al. Cancer Drug Resist 2019;2:912-6 DOI: 10.20517/cdr.2019.02 https://cdrjournal.com/article/view/3197
-
REAL WORLD DATA: Performance of Blood-Based Proteomic Profiling in Immunotherapy-Treated Advanced Stage NSCLC Patients
Rich (Thompson), P et al. 2019 (Multidisciplinary Thoracic Cancers Symposium) & Chuang, Y et al. 2019 (RAS Targeted Drug Discovery Symposium)
-
Biodesix Biopharma Communication in Response to COVID-19
Dear Biopharma Customers,
-
The Nodify XL2™ blood test helps direct next steps in lung nodule management [Video]
-
How Clinics Use a Blood-Based Test to Help Identify Benign Lung Nodules [Video]
-
How Nodify XL2 Helps Relieve Patient Anxiety [Video]
-
Your Blog Post Title Here…